Literature DB >> 6451212

H2-receptors in the human ocular surface.

M B Abelson, I J Udell.   

Abstract

Ten normal human volunteers participated in a two-part study of H2-receptor activity in the ocular surface. Dimethylaminopropylisothiourea (trivial name, dimaprit dihydrochloride), a highly selective H2-receptor agonist, produced vasodilation without itch. Pretreatment with the H2-receptor antagonist, cimetidine, significantly blocked the vasodilatory effect of dimethylaminopropylisothiourea, whereas pretreatment with the H1-receptor antagonist, antazoline phosphate, did not. We conclude that H2-receptors are present in the human ocular surface.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6451212     DOI: 10.1001/archopht.1981.03930010304018

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  15 in total

Review 1.  Ocular allergy treatments.

Authors:  L Bielory
Journal:  Clin Rev Allergy Immunol       Date:  2001-04       Impact factor: 8.667

Review 2.  Efficacy and tolerability of newer antihistamines in the treatment of allergic conjunctivitis.

Authors:  Leonard Bielory; Kenneth W Lien; Steve Bigelsen
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 3.  Antihistamines in ocular allergy: are they all created equal?

Authors:  Mark B Abelson; James T McLaughlin; Paul J Gomes
Journal:  Curr Allergy Asthma Rep       Date:  2011-06       Impact factor: 4.806

Review 4.  Ocular allergy guidelines: a practical treatment algorithm.

Authors:  Leonard Bielory
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 5.  Ocular itch associated with allergic conjunctivitis: latest evidence and clinical management.

Authors:  Stacey Ackerman; Lisa M Smith; Paulo J Gomes
Journal:  Ther Adv Chronic Dis       Date:  2016-01       Impact factor: 5.091

6.  Twice daily 4% Sodium Cromoglycate vs. 2% Sodium Cromoglycate used four times daily in seasonal (grass pollen) allergic conjunctivitis.

Authors:  L M Collum; S Fitzsimon; M Hillery; A Collum; W J Power; Z Pelikan; J B Jenson
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

7.  Levocabastine eye drops in the treatment of vernal conjunctivitis.

Authors:  F Goes; S Blockhuys; M Janssens
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

Review 8.  Efficacy of levocabastine in conjunctival provocation studies.

Authors:  M Janssens
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

Review 9.  New trends in the treatment of allergic conjunctivitis.

Authors:  W Parys; S Blockhuys; M Janssens
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

10.  Evaluation of alcaftadine 0.25% ophthalmic solution in acute allergic conjunctivitis at 15 minutes and 16 hours after instillation versus placebo and olopatadine 0.1%.

Authors:  Jack V Greiner; Kimberly Edwards-Swanson; Avner Ingerman
Journal:  Clin Ophthalmol       Date:  2011-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.